NCT00400218View on ClinicalTrials.gov

Evaluate the Safety and Anti-Hypertensive Efficacy of Hyzaar(R) In Patients With Mild To Moderate Essential Hypertension (0954A-323)

PHASE3CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

September 1, 2005

Primary Completion Date

July 1, 2006

Study Completion Date

July 19, 2006

Conditions
Hypertension
Interventions
DRUG

MK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 12 Weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00400218 - Evaluate the Safety and Anti-Hypertensive Efficacy of Hyzaar(R) In Patients With Mild To Moderate Essential Hypertension (0954A-323) | Biotech Hunter | Biotech Hunter